Principal role of IL-12p40 in the decreased Th1 and Th17 responses driven by dendritic cells of mice lacking IL-12 and IL-18

Cytokine

Volumn 63, Issue 2, 2013, Pages 179-186

  Lim, Hui Xuan ^a   Hong, Hye Jin ^a   Jung, Mi Young ^a   Cho, Daeho ^b   Kim, Tae Sung ^a  

^a Korea University   (South Korea)

^b Sookmyung Women's University   (South Korea)

Author keywords

Dendritic cells; IL 12; IL 18; Th1; Th17

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CELL ANTIGEN; ICOSL PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 18; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOCYTOSIS; FEMALE; GENE SILENCING; IL 12 GENE; IL 18 GENE; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH1 CELL; TH17 CELL; WILD TYPE;

ANIMALS; CELL DIFFERENTIATION; CELL POLARITY; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-17; INTERLEUKIN-18; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TH1 CELLS; TH17 CELLS;

MUS;

EID: 84878980162     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.04.029     Document Type: Article

References (40)

1. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
2. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
3. Inaba K., Witmer-Pack M., Inaba M., Hathcock K.S., Sakuta H., Azuma M., et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994, 180:1849-1860.
4. + subclasses of dendritic cells undergo phenotypic and functional maturation in vitro and in vivo. J Leukocyte Biol 2001, 69:951-958.
5. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003, 3:984-993.
6. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003, 3:133-146.
7. Lebel-Binay S., Berger A., Zinzindohoue F., Cugnenc P., Thiounn N., Fridman W.H., et al. Interleukin-18: biological properties and clinical implications. Eur Cytokine Netw 2000, 11:15-26.
8. Ahn H.J., Maruo S., Tomura M., Mu J., Hamaoka T., Nakanishi K., et al. A mechanism underlying synergy between IL-12 and IFN-γ-inducing factor in enhanced production of IFN-gamma. J Immunol 1997, 159:2125-2131.
9. Trinchieri G., Pflanz S., Kastelein R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003, 19:641-644.
10. Yoshimoto T., Okamura H., Tagawa Y.I., Iwakura Y., Nakanishi K. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci USA 1997, 94:3948-3953.
11. Puccetti P., Belladonna M.L., Grohmann U. Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity. Crit Rev Immunol 2002, 22:373-390.
12. Bastos K.R., Marinho C.R., Barboza R., Russo M., Alvarez J.M., D'Imperio Lima M.R. What kind of message does IL-12/IL-23 bring to macrophages and dendritic cells?. Microbes Infect 2004, 6:630-636.
13. Bastos K.R., de Deus Vieira de Moraes L., Zago C.A., Marinho C.R., Russo M., Alvarez J.M., et al. Analysis of the activation profile of dendritic cells derived from the bone marrow of interleukin-12/interleukin-23-deficient mice. Immunology 2005, 114:499-506.
14. Kinjo Y., Kawakami K., Uezu K., Yara S., Miyagi K., Koguchi Y., et al. Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40. J Immunol 2002, 169:323-329.
15. Kawakami K., Kinjo Y., Uezu K., Miyagi K., Kinjo T., Yara S., et al. Interferon-gamma production and host protective response against Mycobacterium tuberculosis in mice lacking both IL-12p40 and IL-18. Microbes Infect 2004, 6:339-349.
16. + T cells. Eur J Immunol 2007, 37:368-375.
17. Coughlin C.M., Salhany K.E., Wysocka M., Aruga E., Kurzawa H., Chang A.E., et al. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest 1998, 101:1441-1452.
18. Rodriguez-Galan M.C., Reynolds D., Correa S.G., Iribarren P., Watanabe M., Young H.A. Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity. J Immunol 2009, 183:740-748.
19. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992, 176:1693-1702.
20. Yum M.K., Jung M.Y., Cho D., Kim T.S. Suppression of dendritic cells' maturation and functions by daidzein, a phytoestrogen. Toxicol Appl Pharmacol 2011, 257:174-181.
21. Jung M.Y., Son M.H., Kim S.H., Cho D., Kim T.S. IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production. J Immunol 2011, 186:6848-6859.
22. Jung M.Y., Kim H.S., Hong H.J., Youn B.S., Kim T.S. Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to Th1 and Th17 polarization. J Immunol 2012, 188:2592-2601.
23. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995, 182:389-400.
24. Kolb-Maurer A., Kammerer U., Maurer M., Gentschev I., Brocker E.B., Rieckmann P., et al. Production of IL-12 and IL-18 in human dendritic cells upon infection by Listeria monocytogenes. FEMS Immunol Med Mic 2003, 35:255-262.
25. Pulendran B., Palucka K., Banchereau J. Sensing pathogens and tuning immune responses. Science 2001, 293:253-256.
26. Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 1998, 70:83-243.
27. Meyts I., Hellings P.W., Hens G., Vanaudenaerde B.M., Verbinnen B., Heremans H., et al. IL-12 contributes to allergen-induced airway inflammation in experimental asthma. J. Immunol. 2006, 177:6460-6470.
28. Onari Y., Yokoyama A., Haruta Y., Nakashima T., Iwamoto H., Hattori N., et al. IL-12p40 is essential for the down-regulation of airway hyperresponsiveness in a mouse model of bronchial asthma with prolonged antigen exposure. Clin Exp Allergy 2009, 39:290-298.
29. Hayashi N., Yoshimoto T., Izuhara K., Matsui K., Tanaka T., Nakanishi K. T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-γ and IL-13 production. Proc Natl Acad Sci USA 2007, 104:14765-14770.
30. Yamagata S., Tomita K., Sato R., Niwa A., Higashino H., Tohda Y. Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model. Clin Exp Immunol 2008, 154:295-304.
31. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001, 19:423-474.
32. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001, 12:53-72.
33. Yoshimoto T., Tsutsui H., Tominaga K., Hoshino K., Okamura H., Akira S., et al. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci USA 1999, 96:13962-13966.
34. Wang Y., Chaudhri G., Jackson R.J., Karupiah G. IL-12p40 and IL-18 play pivotal roles in orchestrating the cell-mediated immune response to a poxvirus infection. J Immunol 2009, 183:3324-3331.
35. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
36. Hoeve M.A., Savage N.D., de Boer T., Langenberg D.M., de Waal Malefyt R., Ottenhoff T.H., et al. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol 2006, 36:661-670.
37. Ooi J.D., Phoon R.K., Holdsworth S.R., Kitching A.R. IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. J Am Soc Nephrol 2009, 20:980-989.
38. + T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol 2008, 181:8576-8584.
39. Andrews D.M., Chow M.T., Ma Y., Cotterell C.L., Watt S.V., Anthony D.A., et al. Homeostatic defects in interleukin 18-deficient mice contribute to protection against the lethal effects of endotoxin. Immunol Cell Biol 2011, 89:739-746.
40. Lalor S.J., Dungan L.S., Sutton C.E., Basdeo S.A., Fletcher J.M., Mills K.H. Caspase-1-processed cytokines IL-1β and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity. J Immunol 2011, 186:5738-5748.